The role of adult bone marrow derived mesenchymal stem cells, growth factors and carriers in the treatment of cartilage and bone defects

Journal of Stem Cells

Volumn 4, Issue 1, 2009, Pages 71-80

  Salamon, Antal ^a   Toldy, Erzsébet ^b,c  

^a Department of Traumatology ^*  (Hungary)

^b Markusovszky Teaching Hospital   (Hungary)

^c UNIVERSITY OF PÉCS   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; BASIC FIBROBLAST GROWTH FACTOR; BIOMATERIAL; BONE MORPHOGENETIC PROTEIN; COLLAGEN TYPE 1; FIBRIN; GROWTH FACTOR; HYALURONIC ACID; HYDROXYAPATITE; PLATELET DERIVED GROWTH FACTOR; POLYGLACTIN; POLYGLYCOLIC ACID; POLYLACTIC ACID; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; SOMATOMEDIN B; SOMATOMEDIN C; TISSUE SCAFFOLD; TRANSFORMING GROWTH FACTOR BETA; SIGNAL PEPTIDE;

ADULT STEM CELL; ARTICULAR CARTILAGE; BONE DEFECT; BONE GRAFT; BONE MATRIX; CARTILAGE CELL; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CHONDROPATHY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MORBIDITY; NONHUMAN; OSTEOBLAST; PROTEIN FUNCTION; REVIEW; STEM CELL TRANSPLANTATION; TISSUE REPAIR; WOUND HEALING; ADULT; ANIMAL; BONE MARROW; CYTOLOGY; INJURIES; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; TISSUE SCAFFOLD;

ANIMALIA;

ADULT; ANIMALS; BONE MARROW; CARTILAGE, ARTICULAR; CELL DIFFERENTIATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; TISSUE SCAFFOLDS;

EID: 77955251410     PISSN: 15568539     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Tuan, RS; Boland, G; Tuli, R. Adult mesenchymal stem cells and cell based tissue engineering. Arthr. Res. Ther. , 2003, 5, 532-44.
2. Pittenger, MF; Mackay, M; Beck, SC; Jaisval, RK; Dougles, R. et al. Multilineage potential of adult human mesenchymal stem cells. Science, 1999, 284,143-147.
3. Wakitani, S; Goto, T; Pineda, SJ; Young, RG; Mansour, JM; Caplan, AI; Goldberg,VM. Mesenchymal cell-based repair large, full-thickness defects in articular cartilage. J. Bone and Joint Surg., 1994, 76-A, 579-592.
4. Langer, R; Vacanti JP. Tissue engineering. Science, 1993, 260, 920-926.
5. Song; Su Jin; Oju, Jeon; Hee, Seok Yang; Dong, Keun Ham; Byung-Soo Kim. Effect of culture conditions osteogenetic differentiation in human mesenchymal stem cells. J. Microbiol. Biotechnol., 2007, 17, 1113-1119.
6. Maegawa, N; Kavamura, K; Hirose, M; Yajima, H; Takakura, Y; Oghusi, A. Enhancement of osteoblastic differentiation of mesenchymal stem cells cultured by selective combination of bone morphogenetic protein-2 (BMP-2) and Fibroblast growth factor-2 (FGF-2). Tissue Eng. Regen. Med., 2007, 1, 306-313.
7. Niemeyer, P; Krause, V; Punzel, M; Fellenberg, J; Simank, HG. Mesenchymale Stemzellen zum Tissue Engineering von Knochen: Dreidimensionale osteogene Differenzierung auf mineralisierten Kollagen. Z. Orthop., 2003,141, 712-717.
8. Hatakeyama, Y; Nagujen, J; Wang, X; Nuckolls, GH; Shum, L. Smad signaling in mesenchymal and chondroprogenitor cells. J. Bone and Joint Surg., 2003, 85-A, Suppl. 3.13-18.
9. Bruder, SP; Kraus, KH; Goldberg, VG; Kaddiyale, S. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J. Bone and Joint Surg., 1998, 7, 985-996.
10. Nauman A; Dennis, J; Staudenmayer, R; Rotter, N; Aigner, J; Ziegelar, B. et al. Mesenchymale Sammzellen, neue möglichkeiten der Gewebezuchtung für die plastisch-rekonstruktive Chirurgie. Laringo. Rhino-Otologie, 2002, 81, 521-527.
11. Grande, DA; Mason, J; Light, E; Dines, D. Stem cells as platforms for delivery of genes to enhance cartilage repair. J. Bone and Joint Surg., 2003, 85-A, Suppl.2. 111-116.
12. Cheng, H; Jiang, W; Phillips, FM; Haydon, RC; Peng, Y; Zhou, L. et al. Osteogenetic activity of the forteen types of human bone morphogenetic proteins (BMP-s). J. Bone and Joint Surg., 85-A, 2003, 1544-1552.
13. Pitorencu, I; Jinga, VV; Constantinescu, E; Gefencu, AV; Ciohodaru, C; Manolescu, I. et al. Proliferation, differentiation and characterization of osteoblasts for human BM mesenchymal cells. Cytotherapy, 2006, 9, 682-696.
14. Kim, H; Lee. JH; Suh, H. Interaction of mesenchymal stem cells and osteoblasts for in vitro osteogenesis. Yonsei Med. J., 2003, 44, 187-197.
15. Reddi, AH. Bone Morphogenetic Proteins: from basic science to clinical applications. J. Bone and Joint Surg., 2001, 83-A, Suppl.1, 51-456.
16. Zou, L; Zou, X; Mygind, T; Zeng, Y; Lü, N; Bünger C. Molecular mechanism of osteochondroprogenitor fate determination during bone formation. Adv. Exp. Med. Biol., 2005, 585, 3431-5441.
17. Chen, Y; Whetstone, HC; Lin, AC; Nadesan, P; Wei, Q; Poon, R; Alman, B; Beta-Catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing. PloS Med. 2007, 4, 249-57.
18. Kusnetsov, SA; Friedenstein, AJ; Robbey P. Factors required for bone marrow stromal fibroblast colonyformation in vitro. Br. J. Haematol., 1997, 97, 561-570.
19. Caterson, EJ; Nesti, LJ; Albert, T; Danielson, K; Tuan, R. Application of mesenchymal stem cells in the regeneration of musculoskeletal tissues. Med. Gen. Med., 2001, 5, E1.
20. Lieberman, JR; Daluiski, A; Einhorn, A. The role of growth factors in the repair of bone. J. Bone and Joint Surg., 2002, 84-A, 1032-1044.
21. Prockop, JD. Marrow stromal cells as stem cells for nonhematopoetic tissues. Science, 1997, 276, 71-74.
22. Griffith, LG; Naughton, G. Tissue engineering-current challenges and expanding opportunities. Science, 2002, 295, 1009-1018.
23. Salamon, A. Tissue replacement by using biology and biomaterial sciences. Magyar Traumatol, 2005, 48, 340-351.
24. Brooke G; Cook, M; Blair, C; Han, R; Heazleweed, C; Jones,B. et al. Stromal cells. Semin. Cell. Dev. Biol., 2007, 18, 845-858.
25. Dazzi, F; Horwood, NJ. Potential of mesenchymal stem cell therapy. Curr. Opin. Oncol, 2007, 19, 650-655.
26. Sotiropoulou, PA; Papamichail, M. Immune properties of mesenchymal stem cells. Methods Mol. Biol., 2007, 407, 225-243.
27. Spitkovsky, D; Hescheler, J. Adult mesenchymal stromal cells for therapeutic applications. Minim. Invasive Ther. Allied Technol., 2008, 17, 79-90.
28. Ren, G; Zhang, L; Zhao, X; Xu, G; Zhang, Y; Roberts, AI. Mesenchymal stem cell mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell. 2008, 7,141-150.
29. Pelinkovic, D; Horas, U; Engelhard, M; Lee, JY; Huard, J; Fu, FH. Gentherapie von Knorpelgewebe. Z. Orthop., 2002, 140, 153-159.
30. Guo, X; Zheng, Q; Kulbatski, I; Yuan, Q; Yang, S; Shao, Z. Bone regeneration with active angiogenesis by basic fibroblast growth factor gene transfected mesenchymal stem cells seeded on porous beta TPC ceramic scaffolds. Biomed. Mater., 2006, 1, 93-99.
31. Bosch, P; Stice, SL. Adenoviral transduction of mesenchymal stem cells. Methods. Mol. Biol., 2007, 407, 265-274.
32. Martinek, V; Fu, FH; Lee, CW; Huard, J. Treatment of osteochondral injuries. Genetic engineering. Clinics in Sport Med., 2001, 20, 403-416.
33. Schuman, D; Kujat, R; Nerlich, M; Angele, P. Mechanobiological conditioning of stem cells for cartilage tissue engineering. Biomed. Mater. Eng., 2006, 16, (4 Suppl), S.37-52.
34. Solchage, LA; Welter, JF; Lennon, DP; Caplan, AI. Generation of pluripotent stem cells and their differentiation to the chondrocytic phenotype. Methods. Mol. Med., 2004, 100, 53-68.
35. Sato, K; Urist, MR. Bone morphogenetic protein induced cartilage development in tissue culture. Clin. Orthop., 1984, 183, 180-187.
36. Hunziker, EB; Driesang, IR; Morris, EA. Chondrogenesis in cartilage repair is induced by members of the transforming growth factor beta superfamily. Clin. Orthop., 2001, 391, Suppl. S, 171-181.
37. Cook, SD; Patron, LP; Salkeld, SL; Rueger, DC. Repair of articular cartilage defects with osteogenetic protein 1 (BMP-7) in dogs. J. Bone and Joint Surg., 2003, 85-A, Suppl. 3, 116-123.
38. Pacifici, L; Casella, F; Ripari, M. The principles of tissue engineering: role of growth factors in the bone regeneration. Minerva Stomatologica, 2002, 51, 351-359.
39. Kessler, S; Mayr-Wohlfart, U; Ignatius, A; Puhl, W; Claes, L. et al. Der Einfluss von Bone Morphogenetic Protein-2 (BMP-2), Vascular Endothelial Growth Factor (VEGF) und basischem Fibroblastenwachstumfactor (b-FGF) auf Osteointegration, Degradation und biomechanische Eigenschaften eines synthetischen Knochen Ersatzstoffes. Z. Orthop., 2003, 141, 472-480.
40. Cook, SD; Gregory, C; Baffes, BSE; Wolfe, MW; Sampath, TK; Rueger,DC. Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. Clin. Orthop., 1994, 301, 302-312.
41. Govender, Sh; Csimma, C; Genant, HK; Valentin - Opran, A. (BESTT). Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures. J. Bone and Joint Surg., 2002, 84-A, 2123-2134.
42. Bouxsein, ML; Turek, BS; Blake, BSD; Augusta, D; Li,X; Stevens, M. Recombinant human bone morphogenetic protein-2 accerelates healing in a rabbit ulnar osteotomy model. J. Bone and Joint Surg., 2001, 83-A, 1219-1230.
43. Riew, KD; Wright, NM; Cheng, S; Avioli, LV; Lou, J. Indication of bone formation using a recombinant adenoviral carrying the human BMP-2 gene in a rabbit spinal fusion model. Calif. Tissue Int., 1998, 63, 357-360.
44. Lou, J; Xu, F; Merkel, K; Manske, P. Gene therapy: adenovirus- mediated human bone morphogenetic protein -2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivo. J. Orthop. Res., 1999, 17, 43-50.
45. Cheng, SL; Lou, J; Wright, NM; Lai, CF; Avioli, LV; Riew, KD. In vitro and in vivo induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene. Calif. Tissue Int., 2001, 68, 87-94.
46. Koch, H; Jadloviec, JH; Whalen, JD; Lattermann, C; Robbins, P; Fu, FH. et al. Refined adenoviral transduction for controlled gene transfer into human adult mesenchymal stem cells. Z. Orthop., 2005,143, 677-683. (German text).
47. Koch, H; Jadloviec, JH; Whalen, JD; Robbins, P; Lattermann, C; Fu, FH. et al. Osteoblastic differentiation of human adult mesenchymal stem cells after AD-BMP-2 in the abscence of dexamethasone. Z. Orthop., 2005,143, 684-690. (German Text).
48. Bonakovski,D; Mizuno, M; Kim,G, Takagi, S; Okumora, M; Fujinaga, T. Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells (MSCs) in different hydrogels: influence of collagen type II extracellular matrix on MSC chondrogenesis. Biotechnol. Bioeng. 2006,20,1152-1163.
49. Wang,L; Detamore, MS. Insuline like growth factor -I improves chondrogenesis of predifferentiated human umbilical cord mesenchymal stromal cells. Orthop.Res. 2009. Epub ahead of print.
50. Miljkovic, ND; Cooper, GM; Marra, KG. Chondrogenesis, bone morphogenetic protein-4 and mesenchymal stem cells. Osteoarthritis Cartilage, 2008, 16, 1121-1130.
51. Yasko, AW; Lane, JM; Fellinger, EJ; Rosen, V; Wozney, JM; Wang, EA. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). J. Bone and Joint Surg., 1992, 74-A, 659-670.
52. Ruhe, PQ; Hedberg, EL; Padron, NT; Spauwen, PHM; Jansen, JA; Mikos, AG. Rh BMP-2 release from injectable Poly (DL-lactic-co-glycolic acid) calciumphosphate cement composites. J. Bone and Joint Surg., 2003, 85-A, 75-81.
53. den Boer, FC; Wippermann, BW; Blokhuls, TJ; Patka, P; Bakker, FC; Henk, JTh. et al. Healing of segmental bone defects with granular porous hydroxyapatite augmented with recombinant human osteogenetic protein-I or autologous bone marrow. J. Orthop. Res., 2006, 21,521-528.
54. Porada, CD; Zasnjani, ED; Almeida-Porad, G. Adult mesenchymal stem cells: a pluripotent population with multiple applications. Curr. Stem. Cells. Ther., 2006, 1, 135-139.
55. Richter, W. Stem cells and cartilagine regeneration. Akt. Traumatol., 2002, 35, 249-254. (German text).
56. Vilquin, JT; Rosset, P. Mesenchymal stem cells in bone and cartilage repair: current status. Regen. Med., 2006, 1, 589-604.
57. Wakitani, S; Nawata, M; Tensho, K; Okabe, T; Machida, H; Ohgushi, H. Repair of cartilage defects in patellofemoral joint with autologous bone marrow mesenchymal cell transplantation: three cases report involving nine defects in five knees. Tissue Eng. Regen. Med., 2007, 174-79.
58. Hendrich, C; Weber, M; Battmann, A; Steinert, A; Faltin, M; Zimmermann, H. et al. Chondrogene differenzierung von humanen Chondrocyten und mesenchymalen Stammzellen in einem in-vivo Modell. Z. Orthop., 2003, 141, S176.
59. Caplan, AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. Cell Physiol., 2007, 213, 341-347.
60. Einhorn, ThA. Clinical applications of recombinant human BMPs: early experience and future development. J. Bone and Joint Surg., 2003, 85-A, Suppl.3, 82-88.
61. Devine, SM; Peter, S; Martin, BJ. Barry, F; Mc Intosh, KR. Mesenchymal stem cells: stealth and suppression. Cancer Journal, 2001, 7, Suppl. 276-82.
62. Finkemeier, ChG. Bone grafting and bone-graft substitutes. J. Bone and Joint Surg., 2002, 84-A, 454-464.
63. Seeherman, H; Li, R; Wozney, J. A review of preclinical program development for evaluating injectable carriers for osteogenetic factors. J. Bone and Joint. Surg., 2003, 85-A. Suppl.3, 96-108.
64. Food Drug Administration.Document H010002-0P-1. Implant, 2001, Oct.17.
65. Friedlaender, GE; Perry, CR Cole, JD Cook, SD; Cierny, G; Muschler, GF. et al. Osteogenic protein -1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J. Bone and Joint Surg., 2001, 83-A, 151-158.
66. Zimmermann, G; Moghaddam, A; Wagner, C; Vock, B; Wentzenstein, A. Clinical experience with bone morphogenetic protein 7 (BMP 7) in nonunions of long bones. Unfallchirurg, 2006, 109, 528-537. (German text).